200 related articles for article (PubMed ID: 35076335)
21. Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia.
Delgado-Valverde M; Conejo MDC; Serrano L; Fernández-Cuenca F; Pascual Á
J Antimicrob Chemother; 2020 Jul; 75(7):1840-1849. PubMed ID: 32277821
[TBL] [Abstract][Full Text] [Related]
22.
Hackel MA; Tsuji M; Yamano Y; Echols R; Karlowsky JA; Sahm DF
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630181
[TBL] [Abstract][Full Text] [Related]
23. Heteroresistance to cefiderocol in carbapenem-resistant
Longshaw C; Santerre Henriksen A; Dressel D; Malysa M; Silvestri C; Takemura M; Yamano Y; Baba T; Slover CM
Microbiol Spectr; 2023 Dec; 11(6):e0237123. PubMed ID: 37966262
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Humanized Exposures of Cefiderocol (S-649266) against a Diverse Population of Gram-Negative Bacteria in a Murine Thigh Infection Model.
Monogue ML; Tsuji M; Yamano Y; Echols R; Nicolau DP
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848004
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of cefiderocol and comparators against Gram-negative bacterial isolates from a series of surveillance studies in England: 2014-2018.
Gant V; Hussain A; Bain M; Longshaw C; Henriksen AS
J Glob Antimicrob Resist; 2021 Dec; 27():1-11. PubMed ID: 34329792
[TBL] [Abstract][Full Text] [Related]
26.
Wise MG; Karlowsky JA; Hackel MA; Takemura M; Yamano Y; Echols R; Sahm DF
Microb Drug Resist; 2023 Aug; 29(8):360-370. PubMed ID: 37253158
[TBL] [Abstract][Full Text] [Related]
27. Stability and low induction propensity of cefiderocol against chromosomal AmpC β-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae.
Ito A; Nishikawa T; Ota M; Ito-Horiyama T; Ishibashi N; Sato T; Tsuji M; Yamano Y
J Antimicrob Chemother; 2018 Nov; 73(11):3049-3052. PubMed ID: 30188999
[TBL] [Abstract][Full Text] [Related]
28. Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa.
Lasarte-Monterrubio C; Fraile-Ribot PA; Vázquez-Ucha JC; Cabot G; Guijarro-Sánchez P; Alonso-García I; Rumbo-Feal S; Galán-Sánchez F; Beceiro A; Arca-Suárez J; Oliver A; Bou G
J Antimicrob Chemother; 2022 Sep; 77(10):2809-2815. PubMed ID: 35904000
[TBL] [Abstract][Full Text] [Related]
29. Rapid Development of Cefiderocol Resistance in Carbapenem-resistant Enterobacter cloacae During Therapy Is Associated With Heterogeneous Mutations in the Catecholate Siderophore Receptor cirA.
Klein S; Boutin S; Kocer K; Fiedler MO; Störzinger D; Weigand MA; Tan B; Richter D; Rupp C; Mieth M; Mehrabi A; Hackert T; Zimmermann S; Heeg K; Nurjadi D
Clin Infect Dis; 2022 Mar; 74(5):905-908. PubMed ID: 34079986
[TBL] [Abstract][Full Text] [Related]
30. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
Falagas ME; Skalidis T; Vardakas KZ; Legakis NJ;
J Antimicrob Chemother; 2017 Jun; 72(6):1704-1708. PubMed ID: 28369471
[TBL] [Abstract][Full Text] [Related]
31. Contribution of Iron-Transport Systems and β-Lactamases to Cefiderocol Resistance in Clinical Isolates of Acinetobacter baumannii Endemic to New York City.
Asrat H; Samaroo-Campbell J; Ata S; Quale J
Antimicrob Agents Chemother; 2023 Jun; 67(6):e0023423. PubMed ID: 37212653
[TBL] [Abstract][Full Text] [Related]
32. Defining Baseline Mechanisms of Cefiderocol Resistance in the Enterobacterales.
Simner PJ; Beisken S; Bergman Y; Ante M; Posch AE; Tamma PD
Microb Drug Resist; 2022 Feb; 28(2):161-170. PubMed ID: 34619049
[TBL] [Abstract][Full Text] [Related]
33. Relationship of TonB-dependent receptors with susceptibility to cefiderocol in clinical isolates of Pseudomonas aeruginosa.
Gupta A; Landman D; Quale J
J Antimicrob Chemother; 2022 Apr; 77(5):1282-1285. PubMed ID: 35134942
[TBL] [Abstract][Full Text] [Related]
34. Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing.
Matuschek E; Longshaw C; Takemura M; Yamano Y; Kahlmeter G
J Antimicrob Chemother; 2022 May; 77(6):1662-1669. PubMed ID: 35289853
[TBL] [Abstract][Full Text] [Related]
35. Case Report and Genomic Analysis of Cefiderocol-Resistant Escherichia coli Clinical Isolates.
Price TK; Davar K; Contreras D; Ward KW; Garner OB; Simner PJ; Yang S; Chandrasekaran S
Am J Clin Pathol; 2022 Feb; 157(2):257-265. PubMed ID: 34542575
[TBL] [Abstract][Full Text] [Related]
36. Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence.
Viale P; Sandrock CE; Ramirez P; Rossolini GM; Lodise TP
Ann Intensive Care; 2023 Jun; 13(1):52. PubMed ID: 37322293
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of cefiderocol and comparators against isolates of Gram-negative bacterial pathogens from a range of infection sources: SIDERO‑WT‑2014-2018 studies in Spain.
Cercenado E; Cardenoso L; Penin R; Longshaw C; Henriksen AS; Pascual A
J Glob Antimicrob Resist; 2021 Sep; 26():292-300. PubMed ID: 34274538
[TBL] [Abstract][Full Text] [Related]
38. Activity of Cefiderocol, Ceftazidime-Avibactam, and Eravacycline against Carbapenem-Resistant Escherichia coli Isolates from the United States and International Sites in Relation to Clonal Background, Resistance Genes, Coresistance, and Region.
Johnston BD; Thuras P; Porter SB; Anacker M; VonBank B; Snippes Vagnone P; Witwer M; Castanheira M; Johnson JR
Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32718965
[TBL] [Abstract][Full Text] [Related]
39. Case series of cefiderocol for salvage therapy in carbapenem-resistant Gram-negative infections.
Gavaghan V; Miller JL; Dela-Pena J
Infection; 2023 Apr; 51(2):475-482. PubMed ID: 36201152
[TBL] [Abstract][Full Text] [Related]
40. The emergence of cefiderocol resistance in
Teran N; Egge SL; Phe K; Baptista RP; Tam VH; Miller WR
Antimicrob Agents Chemother; 2024 Jan; 68(1):e0100923. PubMed ID: 38063509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
